| Pathway ID | hsa04010 |
| Pathway Term | MAPK signaling pathway |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
|
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
10454 |
Q15750 |
chr22: 39,399,741-39,437,060 |
|
GADD45G |
growth arrest and DNA damage inducible gamma |
10912 |
O95257 |
chr9: 89,605,013-89,606,555 |
|
DUSP10 |
dual specificity phosphatase 10 |
11221 |
Q9Y6W6 |
chr1: 221,701,424-221,742,176 |
|
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
1326 |
P41279 |
chr10: 30,433,937-30,461,833 |
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
1399 |
P46109 |
chr22: 20,917,426-20,953,749 |
|
MAPK14 |
mitogen-activated protein kinase 14 |
1432 |
Q16539 |
chr6: 36,027,677-36,111,236 |
|
GADD45A |
growth arrest and DNA damage inducible alpha |
1647 |
P24522 |
chr1: 67,685,061-67,688,338 |
|
DDIT3 |
DNA damage inducible transcript 3 |
1649 |
P35638 |
chr12: 57,516,588-57,520,517 |
|
DUSP1 |
dual specificity phosphatase 1 |
1843 |
P28562 |
chr5: 172,768,090-172,771,195 |
|
DUSP2 |
dual specificity phosphatase 2 |
1844 |
Q05923 |
chr2: 96,143,166-96,145,440 |
|
DUSP3 |
dual specificity phosphatase 3 |
1845 |
P51452 |
chr17: 43,766,121-43,778,988 |
|
DUSP5 |
dual specificity phosphatase 5 |
1847 |
Q16690 |
chr10: 110,497,838-110,511,544 |
|
DUSP6 |
dual specificity phosphatase 6 |
1848 |
Q16828 |
chr12: 89,347,232-89,353,271 |
|
DUSP7 |
dual specificity phosphatase 7 |
1849 |
Q16829 |
chr3: 52,048,919-52,056,550 |
|
DUSP8 |
dual specificity phosphatase 8 |
1850 |
Q13202 |
chr11: 1,554,044-1,571,920 |
|
DUSP9 |
dual specificity phosphatase 9 |
1852 |
Q99956 |
chrX: 153,642,492-153,651,326 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
ELK1 |
ELK1, member of ETS oncogene family |
2002 |
P19419 |
chrX: 47,635,521-47,650,604 |
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
|
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
|
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
|
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
22800 |
P62070 |
chr11: 14,277,926-14,364,506 |
|
FLNA |
filamin A |
2316 |
P21333 |
chrX: 154,348,524-154,374,638 |
|
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3 |
23162 |
Q9UPT6 |
chr16: 1,706,183-1,770,317 |
|
FLNB |
filamin B |
2317 |
O75369 |
chr3: 58,008,400-58,172,251 |
|
FLNC |
filamin C |
2318 |
Q14315 |
chr7: 128,830,377-128,859,274 |
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
|
MAPK8IP2 |
mitogen-activated protein kinase 8 interacting protein 2 |
23542 |
Q13387 |
chr22: 50,600,685-50,613,981 |
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
2768 |
Q03113 |
chr7: 2,728,112-2,844,324 |
|
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
2872 |
Q9HBH9 |
chr19: 2,037,465-2,051,244 |
|
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
|
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
3164 |
P22736 |
chr12: 52,022,832-52,059,507 |
|
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
3303 |
P0DMV8 |
chr6: 31,815,464-31,817,946 |
|
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
3304 |
P0DMV9 |
chr6: 31,827,735-31,830,255 |
|
HSPA1L |
heat shock protein family A (Hsp70) member 1 like |
3305 |
P34931 |
chr6: 31,809,619-31,815,065 |
|
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
3310 |
P17066 |
chr1: 161,524,540-161,526,910 |
|
HSPB1 |
heat shock protein family B (small) member 1 |
3315 |
P04792 |
chr7: 76,302,544-76,304,295 |
|
FAS |
Fas cell surface death receptor |
355 |
P25445 |
chr10: 88,990,582-89,015,785 |
|
IL1A |
interleukin 1 alpha |
3552 |
P01583 |
chr2: 112,773,915-112,784,590 |
|
IL1B |
interleukin 1 beta |
3553 |
P01584 |
chr2: 112,829,751-112,836,903 |
|
IL1R1 |
interleukin 1 receptor, type I |
3554 |
P14778 |
chr2: 102,064,544-102,179,874 |
|
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
|
JUND |
jun D proto-oncogene |
3727 |
P17535 |
chr19: 18,279,760-18,281,622 |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
|
STMN1 |
stathmin 1 |
3925 |
P16949 |
chr1: 25,884,181-25,906,991 |
|
MAPT |
microtubule associated protein tau |
4137 |
P10636 |
chr17: 45,894,382-46,028,334 |
|
MEF2C |
myocyte enhancer factor 2C |
4208 |
Q06413 |
chr5: 88,717,117-88,904,257 |
|
MAP3K4 |
mitogen-activated protein kinase kinase kinase 4 |
4216 |
Q9Y6R4 |
chr6: 160,991,727-161,117,385 |
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
4217 |
Q99683 |
chr6: 136,557,047-136,792,518 |
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
|
GADD45B |
growth arrest and DNA damage inducible beta |
4616 |
O75293 |
chr19: 2,476,122-2,478,259 |
|
ATF4 |
activating transcription factor 4 |
468 |
P18848 |
chr22: 39,519,695-39,522,685 |
|
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
4772 |
O95644 |
chr18: 79,395,856-79,529,325 |
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
|
NGF |
nerve growth factor (beta polypeptide) |
4803 |
P01138 |
chr1: 115,285,918-115,338,236 |
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
4915 |
Q16620 |
chr9: 84,668,551-85,027,070 |
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
5062 |
Q13177 |
chr3: 196,739,857-196,832,647 |
|
TAOK3 |
TAO kinase 3 |
51347 |
Q9H2K8 |
chr12: 118,149,801-118,372,945 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
NLK |
nemo-like kinase |
51701 |
Q9UBE8 |
chr17: 28,041,737-28,196,381 |
|
ZAK |
Mitogen-activated protein kinase kinase kinase MLT |
51776 |
Q9NYL2 |
chr2: 173,075,435-173,268,010 |
|
PLA2G4A |
phospholipase A2 group IVA |
5321 |
P47712 |
chr1: 186,828,953-186,988,981 |
|
PPM1A |
protein phosphatase, Mg2+/Mn2+ dependent 1A |
5494 |
P35813 |
chr14: 60,245,752-60,299,087 |
|
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent 1B |
5495 |
O75688 |
chr2: 44,167,969-44,244,384 |
|
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 |
Q08209 |
chr4: 101,023,409-101,348,278 |
|
PPP3R2 |
protein phosphatase 3 regulatory subunit B, beta |
5535 |
Q96LZ3 |
chr9: 101,591,615-101,595,021 |
|
PRKACA |
protein kinase, cAMP-dependent, alpha catalytic subunit |
5566 |
P17612 |
chr19: 14,091,688-14,118,084 |
|
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
|
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
|
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
|
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
|
MAPK7 |
mitogen-activated protein kinase 7 |
5598 |
Q13164 |
chr17: 19,377,721-19,383,544 |
|
MAPK8 |
mitogen-activated protein kinase 8 |
5599 |
P45983 |
chr10: 48,306,639-48,439,360 |
|
MAPK9 |
mitogen-activated protein kinase 9 |
5601 |
P45984 |
chr5: 180,233,143-180,292,099 |
|
MAPK13 |
mitogen-activated protein kinase 13 |
5603 |
O15264 |
chr6: 36,127,809-36,144,524 |
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
|
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
5607 |
Q13163 |
chr15: 67,542,709-67,807,123 |
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
5608 |
P52564 |
chr17: 69,414,698-69,543,331 |
|
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
5609 |
O14733 |
chr19: 7,903,843-7,914,478 |
|
TAOK1 |
TAO kinase 1 |
57551 |
Q7L7X3 |
chr17: 29,390,464-29,551,904 |
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 |
P63000 |
chr7: 6,374,523-6,403,977 |
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 |
P15153 |
chr22: 37,225,261-37,244,448 |
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
5881 |
P60763 |
chr17: 82,031,624-82,034,204 |
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
|
RAP1A |
RAP1A, member of RAS oncogene family |
5906 |
P62834 |
chr1: 111,542,218-111,716,691 |
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1 |
5921 |
P20936 |
chr5: 87,267,888-87,391,931 |
|
RASA2 |
RAS p21 protein activator 2 |
5922 |
Q15283 |
chr3: 141,487,047-141,615,342 |
|
CACNG8 |
calcium channel, voltage-dependent, gamma subunit 8 |
59283 |
Q8WXS5 |
chr19: 53,963,040-53,990,215 |
|
CACNG6 |
calcium channel, voltage-dependent, gamma subunit 6 |
59285 |
Q9BXT2 |
chr19: 53,992,288-54,012,669 |
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
|
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
5971 |
Q01201 |
chr19: 45,001,430-45,038,198 |
|
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
6195 |
Q15418 |
chr1: 26,529,761-26,575,030 |
|
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
6196 |
Q15349 |
chr6: 166,409,364-166,906,451 |
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
|
BDNF |
brain-derived neurotrophic factor |
627 |
P23560 |
chr11: 27,654,893-27,722,058 |
|
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
|
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 |
Q07890 |
chr14: 50,117,120-50,231,558 |
|
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
|
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
6885 |
O43318 |
chr6: 90,513,573-90,587,045 |
|
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
|
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
|
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
|
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
|
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
|
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
775 |
Q13936 |
chr12: 1,970,786-2,697,950 |
|
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
777 |
Q15878 |
chr1: 181,413,102-181,808,084 |
|
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
781 |
P54289 |
chr7: 81,946,444-82,443,798 |
|
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
784 |
P54284 |
chr12: 48,813,794-48,828,941 |
|
IL1R2 |
interleukin 1 receptor, type II |
7850 |
P27930 |
chr2: 101,991,844-102,028,544 |
|
DUSP16 |
dual specificity phosphatase 16 |
80824 |
Q9BY84 |
chr12: 12,474,210-12,562,383 |
|
MAP4K3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
8491 |
Q8IVH8 |
chr2: 39,249,266-39,437,312 |
|
MKNK1 |
MAP kinase interacting serine/threonine kinase 1 |
8569 |
Q9BUB5 |
chr1: 46,557,408-46,616,843 |
|
PLA2G4C |
phospholipase A2 group IVC |
8605 |
Q9UP65 |
chr19: 48,047,843-48,110,817 |
|
LAMTOR3 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 |
8649 |
Q9UHA4 |
chr4: 99,878,336-99,894,490 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
8913 |
O43497 |
chr17: 50,561,068-50,627,474 |
|
MAP3K13 |
mitogen-activated protein kinase kinase kinase 13 |
9175 |
O43283 |
chr3: 185,282,941-185,489,097 |
|
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
9252 |
O75582 |
chr14: 90,847,862-91,060,636 |
|
MAPKAPK2 |
mitogen-activated protein kinase-activated protein kinase 2 |
9261 |
P49137 |
chr1: 206,684,944-206,734,283 |
|
CD14 |
CD14 molecule |
929 |
P08571 |
chr5: 140,631,728-140,633,701 |
|
TAOK2 |
TAO kinase 2 |
9344 |
Q9UL54 |
chr16: 29,973,641-29,992,261 |
|
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
9448 |
O95819 |
chr2: 101,696,850-101,894,689 |
|
MAPK8IP1 |
mitogen-activated protein kinase 8 interacting protein 1 |
9479 |
Q9UQF2 |
chr11: 45,885,651-45,906,465 |
|
CDC25B |
cell division cycle 25B |
994 |
P30305 |
chr20: 3,786,772-3,806,121 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
CDC42 |
cell division cycle 42 |
998 |
P60953 |
chr1: 22,052,627-22,092,946 |